The Institute of Medicine (IOM) has acknowledged that there is individual susceptibility to vaccine reactions for genetic, biological and environmental reasons, but that vaccine providers cannot accurately predict prior to a vaccine’s administration who will suffer complications, injury or death from vaccination. However, a person who has previously had a serious reaction to a vaccination or is acutely or chronically ill should become informed about all potential risks associated with vaccination and discuss any concerns with a trusted health care professional before receiving meningococcal vaccine or any other vaccine.
Currently a severe allergic reaction (such as anaphylaxis) after a previous dose of meningococcal vaccine or to any vaccine component is the main CDC approved official contraindication (medical reason for not getting vaccinated) to receiving meningococcal vaccine. Depending on the product, a severe allergic reaction to a diphtheria toxoid or CRM197-containing vaccine (Menveo) or to a tetanus toxoid-containing vaccine (MenQuadfi and Penbraya) is also listed as a contraindication.
A “moderate or severe acute illness with or without fever,” preterm birth in infants younger than nine months of age (Menveo), pregnancy (MenB vaccines) and latex sensitivity (Bexsero) are considered only precautions to vaccination.
IMPORTANT NOTE: NVIC “Quick Facts” is not a substitute for becoming fully informed about Meningococcal disease, meningitis and the Meningococcal vaccine. NVIC recommends consumers read the more complete information following the “Quick Facts”, as well as the vaccine manufacturer product information inserts, and speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child.